Pharmacogenetic angiogenesis profiling for first-line Bevacizumab plus oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer

A Gerger, A El-Khoueiry, W Zhang, D Yang… - Clinical Cancer …, 2011 - AACR
Purpose: There is substantial germline genetic variability within angiogenesis pathway
genes, thereby causing interindividual differences in angiogenic capacity and resistance to …
被引用次数：103 相关文章
[HTML] nih.gov

[HTML][HTML] Pharmacogenetic angiogenesis profiling for first-line bevacizumab plus oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer

A Gerger, A El-Khoueiry, W Zhang, D Yang… - … cancer research: an …, 2011 - ncbi.nlm.nih.gov
Purpose There is substantial germline genetic variability within angiogenesis pathway
genes, thereby causing inter-individual differences in angiogenic capacity and resistance to …
[PDF] researchgate.net

[PDF][PDF] Pharmacogenetic angiogenesis profiling for first-line bevacizumab plus oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer

A Gerger, A El-Khoueiry, W Zhang, D Yang… - Clin Cancer …, 2011 - researchgate.net
Purpose—There is substantial germline genetic variability within angiogenesis pathway
genes, thereby causing inter-individual differences in angiogenic capacity and resistance to …

Pharmacogenetic Angiogenesis Profiling for First-line Bevacizumab plus Oxaliplatin-Based Chemotherapy in Patients with Metastatic Colorectal Cancer

A Gerger, A El-Khoueiry, W Zhang, D Yang… - Clinical Cancer …, 2011 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Purpose: There is substantial germline genetic
variability within angiogenesis pathway genes, thereby causing interindividual differences in …

Pharmacogenetic angiogenesis profiling for first-line Bevacizumab plus oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer

A Gerger, A El-Khoueiry, W Zhang… - … : an official journal …, 2011 - pubmed.ncbi.nlm.nih.gov
Purpose There is substantial germline genetic variability within angiogenesis pathway
genes, thereby causing interindividual differences in angiogenic capacity and resistance to …

[引用][C] Pharmacogenetic Angiogenesis Profiling for First-line Bevacizumab plus Oxaliplatin-Based Chemotherapy in Patients with Metastatic Colorectal Cancer

A GERGER, A EL-KHOUEIRY… - Clinical cancer …, 2011 - pascal-francis.inist.fr
Pharmacogenetic Angiogenesis Profiling for First-line Bevacizumab plus Oxaliplatin-Based
Chemotherapy in Patients with Metastatic Colorectal Cancer CNRS Inist Pascal-Francis CNRS …

Pharmacogenetic angiogenesis profiling for first-line Bevacizumab plus oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer

A Gerger, A El-Khoueiry, W Zhang, D Yang… - Clinical Cancer …, 2011 - pure.qub.ac.uk
PURPOSE: There is substantial germline genetic variability within angiogenesis pathway
genes, thereby causing interindividual differences in angiogenic capacity and resistance to …
[PDF] academia.edu

[PDF][PDF] Pharmacogenetic angiogenesis profiling for first-line bevacizumab plus oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer

A Gerger, A El-Khoueiry, W Zhang, D Yang… - Clin Cancer …, 2011 - academia.edu
Purpose—There is substantial germline genetic variability within angiogenesis pathway
genes, thereby causing inter-individual differences in angiogenic capacity and resistance to …

Pharmacogenetic angiogenesis profiling for first-line Bevacizumab plus oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer.

A Gerger, A El-Khoueiry, W Zhang, D Yang… - … Cancer Research: an …, 2011 - europepmc.org
Purpose There is substantial germline genetic variability within angiogenesis pathway
genes, thereby causing interindividual differences in angiogenic capacity and resistance to …
[PDF] academia.edu

[PDF][PDF] Pharmacogenetic angiogenesis profiling for first-line bevacizumab plus oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer

A Gerger, A El-Khoueiry, W Zhang, D Yang… - Clin Cancer …, 2011 - academia.edu
Purpose—There is substantial germline genetic variability within angiogenesis pathway
genes, thereby causing inter-individual differences in angiogenic capacity and resistance to …